Min–Ho Oak
Impact in
- Biochemistry top 1%
- Phytochemicals and Antioxidant Activities
- Antioxidant Activity and Oxidative Stress
- Eicosanoids and Hypertension Pharmacology
- Geriatrics and Gerontology top 5%
Papers in
-
- Receptor Mechanisms and Signaling 5
-
- Cardiac Valve Diseases and Treatments 7
- Blood Pressure and Hypertension Studies 4
- Co-authors
- Valérie B. Schini‐Kerth (15 shared papers)Thierry Chataigneau (2 shared papers)Jean‐Claude Stoclet (1 shared paper)Mamadou Ndiaye (1 shared paper)Marta Chataigneau (1 shared paper)Sin‐Hee Park (12 shared papers)Kyeong‐Man Kim (8 shared papers)Valérie B. Schini-Kerth (2 shared papers)
- Journals
- Journal of Nanoscience and Nanotechnology (7 papers)Cardiovascular Research (4 papers)Biochemical Pharmacology (3 papers)Archives of Pharmacal Research (3 papers)Atherosclerosis (3 papers)
- Partner nations
- South KoreaFranceUnited States
In The Last Decade
Min–Ho Oak
69 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 121
- Biochemistry 460
- Geriatrics and Gerontology 47
- Pharmacology 122
- Complementary and alternative medicine 111
- Biochemistry 98
Countries citing papers authored by Min–Ho Oak
This map shows the geographic impact of Min–Ho Oak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min–Ho Oak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min–Ho Oak more than expected).
Fields of papers citing papers by Min–Ho Oak
This network shows the impact of papers produced by Min–Ho Oak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min–Ho Oak. The network helps show where Min–Ho Oak may publish in the future.
Co-authors
The 25 scholars most cited alongside Min–Ho Oak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 446 | |
| 2 | 2006 | 146 | |
| 3 | 1998 | 118 | |
| 4 | 2018 | 97 | |
| 5 | 2015 | 92 | |
| 6 | 2012 | 67 | |
| 7 | 2022 | 63 | |
| 8 | 2005 | 62 | |
| 9 | 2004 | 58 | |
| 10 | 2017 | 49 | |
| 11 | 2012 | 47 | |
| 12 | 2017 | 44 | |
| 13 | 2016 | 41 | |
| 14 | 2019 | 36 | |
| 15 | 2023 | 32 | |
| 16 | 2008 | 32 | |
| 17 | 2018 | 23 | |
| 18 | 2016 | 22 | |
| 19 | 2008 | 20 | |
| 20 | 2015 | 19 |
About Min–Ho Oak
Min–Ho Oak is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Immunology, Physiology and Pathology and Forensic Medicine, having authored 73 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (8 papers), Cardiac Valve Diseases and Treatments (7 papers), Antioxidant Activity and Oxidative Stress (6 papers), Atherosclerosis and Cardiovascular Diseases (6 papers), Receptor Mechanisms and Signaling (5 papers), Tea Polyphenols and Effects (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). The work is most often cited by research in Biochemistry (460 citations), Geriatrics and Gerontology (47 citations), Pharmacology (122 citations), Complementary and alternative medicine (111 citations) and Biochemistry (98 citations). Min–Ho Oak has collaborated with scholars based in South Korea, France and United States. Frequent co-authors include Valérie B. Schini‐Kerth, Thierry Chataigneau, Jean‐Claude Stoclet, Mamadou Ndiaye, Marta Chataigneau, Sin‐Hee Park, Kyeong‐Man Kim, Valérie B. Schini-Kerth, Patrick Anglard and Hyun-Ho Lee. Their work appears in journals such as Journal of Nanoscience and Nanotechnology, Cardiovascular Research, Biochemical Pharmacology, Archives of Pharmacal Research and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.